Cite
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease
MLA
Chris C. Tang, et al. Long-Term Follow-up of a Randomized AAV2-GAD Gene Therapy Trial for Parkinson’s Disease. Apr. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....572a23197004ab897af1d757a33c9826&authtype=sso&custid=ns315887.
APA
Chris C. Tang, Peter A. LeWitt, Kathleen L. Poston, Andrew Feigin, Matthew J. During, Jaimie M. Henderson, Mustafa S. Siddiqui, David Eidelberg, Maureen A. Leehey, Steven G. Ojemann, Alice W. Flaherty, Stephen B. Tatter, Emad N. Eskandar, Jason M. Schwalb, Sandra K. Kostyk, Martin Niethammer, Roger Kurlan, Irene H. Richard, Ali R. Rezai, … Christine V. Sapan. (2017). Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease.
Chicago
Chris C. Tang, Peter A. LeWitt, Kathleen L. Poston, Andrew Feigin, Matthew J. During, Jaimie M. Henderson, Mustafa S. Siddiqui, et al. 2017. “Long-Term Follow-up of a Randomized AAV2-GAD Gene Therapy Trial for Parkinson’s Disease,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....572a23197004ab897af1d757a33c9826&authtype=sso&custid=ns315887.